William Carson Email & Phone Number
@decibeltx.com
1 phone found area 301
LinkedIn matched
Who is William Carson? Overview
A concise factual answer block for searchers comparing this professional profile.
William Carson is listed as Director at Excision BioTherapeutics, a with 1001 employees, based in Miami Beach, Florida, United States. AeroLeads shows a work email signal at decibeltx.com, phone signal with area code 301, and a matched LinkedIn profile for William Carson.
William Carson previously worked as Board of Directors at Lutron Electronics and Board of Directors at Annexon Biosciences (Nasdaq: Annx). William Carson holds Corporate Director Certification from Harvard Business School Executive Education.
Email format at Excision BioTherapeutics
This section adds company-level context without repeating William Carson's masked contact details.
AeroLeads found 1 current-domain work email signal for William Carson. Compare company email patterns before reaching out.
About William Carson
With over 10 years of board leadership and pharmaceutical executive experience, I am passionate about developing and commercializing innovative therapies that improve the lives of patients and society. I currently serve as the Chairman of the Board at Decibel Therapeutics (NASDAQ: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders.In addition, I am an Independent Board Director at Annexon Biosciences (NASDAQ: ANNX), a clinical-stage biopharmaceutical company developing novel therapies for autoimmune and neurodegenerative diseases; a Board Director at Excision BioTherapeutics, a gene therapy company focused on curing viral infectious diseases; and a Board Director at Lutron, a leader in smart lighting and shading solutions. I also hold a Corporate Director Certification from Harvard Business School Executive Education, and I have extensive experience in executive, nominating and governance, compensation, science and technology, and audit committees. I leverage my expertise in product acquisitions, clinical trials, and clinical development to support the strategic vision, growth, and performance of these organizations.
Listed skills include Clinical Development, Clinical Trials, Pharmaceutical Industry, Clinical Research, and 16 others.
William Carson's current company
Company context helps verify the profile and gives searchers a useful next step.
William Carson work experience
A career timeline built from the work history available for this profile.
Board Of Directors
CurrentIndependent Director and Chair of the Talent and Compensation Committee. Lutron Electronics which is privately held, specializes in energy-saving lighting, shade, and temperature control systems.
Board Of Directors
CurrentIndependent Director and Chair of the Science and Technology Committee. Annexon is bringing game-changing therapies to patients suffering from serious complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders.
Advisor
Current
Chairman Of The Board
CurrentAbout the Sozosei FoundationThe Sozosei Foundation is a U.S.-based, private charitable foundation committed to the health and well-being of our communities, including improved patient diagnosis, treatment, care and quality of life, especially for those patients who are most in need.
Director
CurrentUNPARALLELED RESEARCH ENDLESS POSSIBILITIESThe Excision BioTherapeutics team includes some of the top biochemistry, chemistry and molecular biology experts with concentrations in the fields of retrovirology, virology, viral genetics, bioinformatics, and advanced drug delivery.AREAS OF FOCUS:Human Immunodeficiency Virus-1 TherapeuticsJC Virus and Progressive Multifocal LeukoencephalopathyHerpes Simplex Virus 1 and 2 TherapeuticsHepatitis B Virus TherapeuticsAdvanced DNA and Biologic Delivery Systems
Chairman Of The Board
Chairman Of The Board
Director
Trustee
Internet2 is a member-driven advanced technology community founded by the nation’s leading higher education institutions in 1996. Internet2 provides a collaborative environment where US research and education organizations can solve common technology challenges and develop innovative solutions in support of their educational, research and community service missions. Our community touches nearly every major innovation that defines our modern digital lives—and continues to define “what’s next.” Internet2 operates the nation’s largest and fastest, coast-to-coast research and education network that was built to deliver advanced, customized services that are accessed and secured by the community-developed trust and identity framework, with Internet2 Network Operations Center powered by Indiana University. Internet2 serves 317 U.S. universities, 60 government agencies, 43 regional and state education networks and through them supports more than 100,000 community anchor institutions, close to 1,000 InCommon participants, and 59 leading corporations working with our community, and 70 national research and education network partners that represent more than 100 countries.
Board Member
President & Ceo
Serve as hands-on executive leader for this wholly owned subsidiary of Otsuka, Inc., which has developed compounds to treat disorders in neuroscience, oncology, and cardio-renal therapeutic areas.►Tasked by board of Otsuka Pharmaceutical Japan to lead enterprise-wide globalization effort to streamline and harmonize what was a regionally fragmented pharmacovigilance and safety program.►Entered into exclusive, worldwide license and collaboration agreement with Proteus Digital Health, Inc. to develop and commercialize new category of medicines based on Otsuka’s pharmaceutical products and Proteus’s digital health feedback system.►Delivered global clinical development outcomes including: Abilify Maintena® (long acting depot formulation) approved Feb. 2013 in US and Sept. 2013 in EU; Rexulti™ (brexpiprazole) approved July 2015 in US; and approval by Japan PMDA and EMA for tolvaptan for treatment of polycystic Kidney Disease (PKD).
Svp, Global Clinical Development (2008-2010) Vp, Global Clinical Development (2007-2008)
Added ongoing value as head of global R&D for Otsuka’s global products. Maintained accountability for central nervous system (CNS) compounds, including Abilify (indications not being developed by BMS) and Brexpiprazole; for cardio-renal compound Tolvaptan; oncology compounds Busulfex and Sativex (developed with GW Pharma).
Vice President, Cns / Aripiprazole
Served as clinical co-chair for Otsuka-BMS alliance for Aripiprazole leading up to approval and 2002 launch of Abilify. Established positive, ongoing relationships with worldwide colleagues.
Group Director
Associate Professor, Department Of Psychiatry
Colleagues at Excision BioTherapeutics
Other employees you can reach at lutron.com. View company contacts for 1001 employees →
Stephen Kowalchuk
Colleague at Excision BiotherapeuticsCenter Valley, Pennsylvania, United States
View →
KQ
Kaitlyn Quinn
Colleague at Excision BiotherapeuticsAustin, Texas, United States
View →
BS
Braden Simpson
Colleague at Excision BiotherapeuticsBethlehem, Pennsylvania, United States
View →
JA
Jose Angel Briones
Colleague at Excision BiotherapeuticsLos Angeles, California, United States
View →
JD
Jeferson Delgado
Colleague at Excision BiotherapeuticsAllentown, Pennsylvania, United States
View →
EL
Emily Logemann
Colleague at Excision BiotherapeuticsCosta Mesa, California, United States
View →
MZ
Maddie Zyck
Colleague at Excision BiotherapeuticsDallas, Texas, United States
View →
GS
Gagandeep Singh
Colleague at Excision BiotherapeuticsGreater Toronto Area, Canada
View →
RN
Russ Nunan
Colleague at Excision BiotherapeuticsBath, Pennsylvania, United States
View →
LS
Liliana Sanchez Rodriguez
Colleague at Excision BiotherapeuticsChihuahua, Mexico
View →
William Carson education
Corporate Director Certification
M.D., Medicine
A.B., History And Science
Psychiatry Residency
Corporate Director Certification
Frequently asked questions about William Carson
Quick answers generated from the profile data available on this page.
What company does William Carson work for?
William Carson works for Excision BioTherapeutics.
What is William Carson's role at Excision BioTherapeutics?
William Carson is listed as Director at Excision BioTherapeutics.
What is William Carson's email address?
AeroLeads has found 1 work email signal at @decibeltx.com for William Carson at Excision BioTherapeutics.
What is William Carson's phone number?
AeroLeads has found 1 phone signal(s) with area code 301 for William Carson at Excision BioTherapeutics.
Where is William Carson based?
William Carson is based in Miami Beach, Florida, United States while working with Excision BioTherapeutics.
What companies has William Carson worked for?
William Carson has worked for Excision Biotherapeutics, Lutron Electronics, Annexon Biosciences (Nasdaq: Annx), Bexson Biomedical, and Sozosei Foundation.
Who are William Carson's colleagues at Excision BioTherapeutics?
William Carson's colleagues at Excision BioTherapeutics include Stephen Kowalchuk, Kaitlyn Quinn, Braden Simpson, Jose Angel Briones, and Jeferson Delgado.
How can I contact William Carson?
You can use AeroLeads to view verified contact signals for William Carson at Excision BioTherapeutics, including work email, phone, and LinkedIn data when available.
What schools did William Carson attend?
William Carson holds Corporate Director Certification from Harvard Business School Executive Education.
What skills is William Carson known for?
William Carson is listed with skills including Clinical Development, Clinical Trials, Pharmaceutical Industry, Clinical Research, Neuroscience, Commercialization, Drug Development, and Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial